Comparative Evaluation of Biodentine and Bioceramic as Pulp Medicaments Following Laser and Conventional Pulpotomy in Primary Molars: A Double-blind Randomized Controlled Trial

The purpose of this randomized controlled trial was to evaluate and compare the clinical and radiographic success of Biodentine and Bioceramic putty as pulp medicaments following diode laser-assisted and conventional pulpotomy in primary molars. Forty-eight primary molars in children aged 4–9 years were randomly assigned into four groups ( n = 12 each): Conventional pulpotomy with Biodentine, conventional pulpotomy with Bioceramic, laser-assisted pulpotomy with Biodentine, and laser-assisted pulpotomy with Bioceramic. Clinical and radiographic outcomes were evaluated at 1, 3, and 6 months using Zurn and Seale criteria (2008). Data were analyzed with one-way ANOVA, with significance set at P < 0.05. All groups showed favorable clinical and radiographic success at 6 months. The laser–Bioceramic group demonstrated the highest overall success (83.2%), followed by laser–Biodentine (75%) and conventional Bioceramic (75%), whereas conventional Biodentine showed comparatively lower success (50%). Differences among groups were not statistically significant ( P > 0.05). Both Biodentine and Bioceramic were effective pulpotomy medicaments in primary molars, with Bioceramic showing slightly better outcomes. Laser-assisted pulpotomy provided additional clinical benefits, particularly in enhancing hemostasis and healing, although the differences were not statistically significant.